Abbott | ABT - Ordinary Share Capital




Abbott reported $25.02B in Ordinary Share Capital for its fiscal quarter ending in September of 2024.

Ordinary Share Capital Change Date
Abbott USD 25.02B 408M Sep/2024
Agilent USD 3M 0 Oct/2024
AtriCure USD 49K 0 Sep/2024
Baxter International USD 683M 0 Sep/2024
Becton, Dickinson and Co. USD 371M 0 Sep/2024
Bio-Rad Laboratories USD 3K 0 Sep/2024
Boston Scientific USD 17M 0 Sep/2024
Cooper Companies USD 21.7M 0 Oct/2024
Danaher USD 9M 0 Dec/2024
Dexcom USD 400K 0 Sep/2024
Edwards Lifesciences USD 654.3M 800K Sep/2024
Globus Medical USD 135K 0 Sep/2024
Hologic USD 3M 0 Sep/2024
Insulet USD 100K 0 Jun/2024
Integra LifeSciences USD 916K 0 Sep/2024
Intuitive Surgical USD 400K 0 Sep/2024
J&J USD 3.12B 0 Sep/2024
Masimo USD 100K 0 Sep/2024
Medtronic USD 128K 0 Oct/2024
Merit Medical Systems USD 669.21M 10.48M Sep/2024
Smith & Nephew USD 175M 0 Dec/2023
Solventum Corp 2M 0 Sep/2024
Stryker USD 38M 0 Sep/2024
Tandem Diabetes Care USD 66K 1000 Sep/2024
Teleflex USD 48.1M 5K Sep/2024
Terumo JPY 38.72B 0 Sep/2024
Thermo Fisher Scientific USD 442M 1000K Sep/2023
Zimmer Biomet Holdings USD 3.2M 0 Sep/2023